1

C U R R I C U L U M V I T A E

Vasile Daniel

Conferentiar universitarMedic primar psihiatru

Doctor in stiinte medicaleSef Clinica Psihiatrie

Nume: - Vasile Daniel

Data nasterii: - 29.04.1963

Studii: - Facultatea de Medicină Militara, I.M.F. Bucuresti, 1987

Limbi străine: - Engleza nivel C1 conform Cadrului Comun European de Referinţă - Franceză nivel B2 conform Cadrului Comun European de Referinţă

Evoluţie profesionalã:- Medic stagiar in Spitalul Militar Central 1987-1990- Medic secundar prin concurs specialitatea psihiatrie,

Clinica Psihiatrie - Spitalul Prof. Gh. Marinescu -Bucuresti 1990

- Medic specialist psihiatru, 1994- Participant la misiunea “Restore Hope”, Somalia, 1994- Medic primar psihiatru 1998- Doctor in stiinte medicale, 2001 (U.M.F. Carol Davila,

Bucuresti)- Lector sub egida European Addiction Training Institute,

Amsterdam : « New approaches in Drug and Alcohol Dependence Treatment », 2002

- Invited speaker la 7th Regional Meeting of European College of Neuropsychopharmacology, 2002

- Membru in Comisia de sustinere a concursului de specialitate, disciplina Psihiatrie, 2002

2

- Coordonator de centru de studii în cadrul studiului EUFEST (European First Episode of Schizophrenia) desfăşurat sub egida Uniunii Europene.

- Sef de lucrări, UMF Carol Davila Bucuresti, 2003- Sef al Sectiei Psihiatrie din cadrul Spitalului Clinic de

Urgenta Militar Central „Carol Davila”, Bucuresti, iulie 2007

- Conferentiar universitar Psihofarmacologie Clinica UMF Carol Davila Bucuresti, octombrie 2009

CARTI PUBLICATE

Dependenţa de heroină Editura Medicală Amaltea, 2001D. Vasile , M.D. Gheorghe, V. Voicu

Mit şi realitate în mecanismul dependenţei la benzodiazepineEditura Medicală Amaltea Bucureşti, 2003D. Vasile

Abordari terapeutice cognitiv-comportamentale in cazul dublului diagnostic depresie-tulburare de personalitateEditura Printech Bucuresti, 2007D. Vasile, O. Vasiliu

Terapia farmacologica a tulburarilor anxioase – cursEditura Printech Bucuresti, 2008D. Vasile, O. Vasiliu

Evaluarea si managementul riscului suicidar in tulburarile de personalitateEditura Printech Bucuresti, 2008D. Vasile, O. Vasiliu

Factori de vulnerabilitate in toxicomaniiEditura Printech Bucuresti, 2009D. Vasile, O. Vasiliu

Abordari terapeutice in dependenta de substanteEditura Printech Bucuresti, 2009D. Vasile, O. Vasiliu

3

Psihopatologie generala, vol.I – Semiologie psihiatrica – cursEditura Printech Bucuresti, 2009D. Vasile, O. Vasiliu

Psihopatologie generala, vol.II – Sindromologie psihiatrica – cursEditura Printech Bucuresti, 2009D. Vasile, O. Vasiliu

Factorii compliantei terapeutice in psihiatrieEditura Printech Bucuresti, 2009D. Vasile, O. Vasiliu

Psihofarmacologie clinică interactivă.Teste comentateEd. Printech, Bucure�ti, 2013D. Vasile, O.Vasiliu

CAPITOLE DIN MONOGRAFII

Actualităţi în psihiatria biologicăEditura Intact, 1999Coautor la capitolul „Suicidul –o placă turnantă a psihiatriei moderne”

The Role of the Muscarinic Receptors and of the Nitric Oxide in the Morphinic WithdrawalGlissando Ed. Iasi, 2001D.Vasile, M.D.Gheorghe In: „Pharmacodependences Mechanism Clinical Aspects, Treatment”

Semiologie si sindromologie psihiatricaEditura Universitatii « Carol Davila », 2002 coautor la capitolul « Semiologie psihiatrica orientativa »

Aspecte bioetice ale abordării pacientului în psihooncologieO.Vasiliu, D.Vasile în „Standarde europene pentru programe postdoctorale competitive de formare în domeniul managementului cercetării avansate şi expertizei psihiatrice medico-legale”, IML Iaşi, Ed.Timpul, Iaşi, 2013

CURSURI POSTUNIVERSITARE DE PERFECTIONARE IN TARA:

1. U.M.F. « Carol Davila » Bucuresti ; specializarea Neurologie- Urgente neurologice : diagnostic clinic si tratament, 1998

4

2. U.M.F. « Carol Davila » Bucuresti ; specializarea Psihiatrie-Urgente psihiatrice : diagnostic clinic si tratament, 1998

3. Centrul de Perfectionare Postuniversitara a Medicilor si Farmacistilor-S.M.C. Bucuresti- : Strategii terapeutice actuale in practica psihiatrica, 1999

4. Centrul de Perfectionare Postuniversitara a Medicilor si Farmacistilor-S.M.C. Bucuresti-Introducere in neurochimia psihiatrica, 1999

5. Centrul de Politici si Servicii de Sanatate, in colaborare cu Open Society Institute New York- Sinaia- : « Implementing Effective Drug Substitution Therapy in Romania »,2000

6. Managementul sistemului de sănătate. Masterat la Universitatea Bucureşti, Facultatea de Sociologie şi Asistenţă Socială, 2009

7. Managementul serviciilor de sănătate, Şcoala Naţională de Sănătate Publică şi Management Sanitar, 2010

CURSURI POSTUNIVERSITARE DE PERFECTIONARE IN STRAINATATE :

1. Reseau Ville- Hopital Toxicomanies de Lyon, France : Stage complete sur le dispositif specifique de prise en charge des personnes presentant une pharmacodependance, 2000

2. Centre Hộpitalier Universitaire Bergmann, Bruxelles, Belgium-Stage dans la Clinique d’ Alcoologie et des Toxicomanies, 2000

3. Centre Medical Enaden, Bruxelles, Belgium-Toxicomanies- Alcool, drogues, Medicaments, 2000

4. European Addiction training Institute- Antwerp, Belgium : « Techniques of Relapse Prevention of Addictive Behaviours », 2001

5. Hộpital Erasme, Bruxelles, Belgium- Stage de formation dans le service de psychiatrie et au Laboratoire du sommeil conduit par le Professeur Julien Mendlewicz,2001

6. Jellinek Centre and the European Addiction Training Institute, Amsterdam, Holland : Program with experts of the Jellinek, 2001

7. Université Libre de Bruxelles- Centre Hospitalier Universitaire Bergmann, Bruxelles, Belgium-Psychoses et troubles de l’humeur, 2001

8. Institut de Psychiatrie et de Psychologie Medicale Bruxelles, Belgium :Techniques d’electrophysiologie diagnostique adaptée aux patients psychiatriques, 2001

9. Unitas de conduitas addictivas, Valencia, Espana : Los tratamientos para los addictivos, 2002

10.Hospital Universitario de San Juan, Alicante, Espana : Programa DRAO en el Servicio de Medicina Intensiva, 2002

11.Seminaires de formation en psycho-oncologie, Bucharest, 2004

5

CERCETĂRI FARMACOCLINICE

1. European First Episode of Schizophrenia Trial (EUFEST), Site Coordinator, 2002-2006

2. RIS-SCP-402 Safety Risperidone vs Quetiapine vs placebo in patients with acute exacerbation of schizophrenia or schizo-affective disorders, 2004;

3. A multicenter, randomized, double-blind, fixed-dose, 6-week trial of the efficacy and safety of asenapine compared to placebo using haloperidol positive control in subjects with an acute exacerbation of schizophrenia, Phase III, 2005-2006, Principal Investigator.

4. A multicenter, double-blind, flexible-dose, long-term extension trial of the safety and maintenance of effect of asenapine using a haloperidol positive control in subjects who complete protocol 041023, Phase III, 2006-2007, Principal Investigator.

5. A randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Flexible Dose Paliperidone ER in the Treatment of Subjects with Schizoaffective Disorder, Phase III, 2007-2008, Principal Investigator.

6. An open-label, multi-center, 6-week, sequential cohort study designated to determine the safety and tolerability of two dose ranges of BL-1020 in hospitalized subjects with chronic schizophrenia or schizo-affective disorder, Phase IIa, 2007-2008, Principal Investigator.

7. A six-week, randomized, double-blind, placebo controlled, parallel, multicenter, IIb phase study to determine the efficacy, safety, and tolerance of non-overlapping low and high doses of BL-1020 versus placebo and risperidone in patients with acute exacerbations of schizophrenia, 2008-2009, Principal Investigator.

8. A multicenter, Inpatient and ambulatory, Phase 2, Double-blind, Randomised, Placebo-controlled, Proof of Concept Study of CYR-101 in Patients with DSM-IV Schizophrenia, 2008-2009, Country Coordinator.

9. A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawall, Parallel Group Study to Evaluate the Efficacy and Safety of 50 mg/day of DVS SR in Adult Outpatients With Major Depressive Disorder, phase III, 2009-2010, Principal Investigator.

10. A randomized, 6-week, double-blind, placebo-controlled, flexible-dose, parallel-group study of lurasidone adjunctive to lithium or divalproex for the treatment of the treatment of bipolar I depression, phase III, 2009-2010, Principal Investigator.

11. A randomized, 6-week, double-blind, placebo-controlled, fixed-flexible-dose, parallel-group study of lurasidone adjunctive to lithium or

6

divalproex for the treatment of the treatment of bipolar I depression, phase III, 2009-2010, Principal Investigator.

12. A 24-week, flexible-dose, open-label, extension study of lurasidone for the treatment of bipolar I depression, phase III, 2009-2010, Principal Investigator.

13. A 8-week, randomised, double-blind, flexible-dose, parallel groups, placebo-controlled, international, multicenter study followed by an extension double-blind treatment period of 16 weeks, phase III, 2009-2010, Principal investigator.

14. A 52-week, 2 period, multicenter, randomized, double-blind, donepezil-referenced, placebo-controlled, efficacy and safety study of 3 dosage levels of SAM-531 in outpatients with mild to moderate Alzheimer disease, phase 2b, 2009-2010, Principal Investigator.

15. A phase 2, 6-week, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of oral OPC-34712 once daily aripiprazole once daily for treatment of hospitalized adult patients with acute schizophrenia, 2010, Principal Investigator.

16. A phase 2, multicenter, open-label study to assess the safety and tolerability of oral OPC-34712 as monotherapy in adult patients with schizophrenia, 2010, Principal Investigator.

PARTICIPARI LA MANIFESTARI STIINTIFICE NATIONALE SI INTERNATIONALE

1. 17 th Danube Symposium of Psychiatry,Timişoara-Romania, 24-27 Aprilie, 1996

2. 1st Congress of Balkan Military Medical Committee, Istanbul-Turcia, 6-8 Mai, 1996

3. International Conference on Suicide: Biopsychosocial Approaches Atena-Grecia, 16-19 Mai, 1996

4. IVth Salon International Psy & SNC, Paris-Franţa, 15-19 Octombrie, 1996

5. 2nd Congress of the Balkan Military Medical Committee, Sofia-Bulgaria, 6-9 Octombrie, 1997

6. 4th Congress of the Balkan Military Medical Committee Bucarest, 6-9 June, 1999

7. XXth Congress of the International Association for Suicide Prevention, 6-10 Nov., Athens-Greece,1999

8. 5th Congress of Balkan Military Medical Comitee, Ankara-Turkey, 25-28 Sept., 2000

7

9. Implementing Effective Drug Substitution Therapy in Romania, 18-21 sept. 2000 Sinaia, simpozion organizat de Open Society Institute New York and Center for Health Policies and Services

10. 10 th Association of European Psychiatrists Congress, Praga 28 Oct-1 Nov, 2000

11. Alzheimer Europe 11th Conference June 10-12, 2001, Bucharest,Romania

12. 7th World Congress Biological Psychiatry 1-6 July 2001 Berlin, Germany

13. 7th Regional Meeting of European College of Neuropsychopharmacology, Bucharest,19-21 Aprilie 2002

14. 5th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Constanta, 29mai-01iun.2002

15. 3th Regional Meeting: Financing Mintal and Addictive Disorders in Central and Eastern Europe, Bucharest, 23-25.11.2001

16. 15th Congress of the European College of Neuropsychopharmacology, Barcelona, Spain, October 5-9, 2002

17. 3rd Conference of International Early Psychosis Association, Copenhagen, Denmark, 24-28 September, 2002.

18. „Global Adivsory Forum – Risperdal Consta”Cannes - Franţa, 9-10 November, 2003

19. AEP Spring Symposium „Memories”, Roma - Italia, 24 –26 april, 2003 21. 8th Congress of BMMC, Cluj,2003 22. Forumul de psihiatrie, 2004. 23. 12th WPA International Congress, Florenta, nov. 2004 24. 17th ECNP Congress, Stockholm, oct.2004 25. International Congress of Biological Psychiatry, Sydney, feb. 2004 26. Conferinta Nationala de Terapie si Management in Psihiatrie, sept.-oct. 2004, Craiova 27. Forumul de Psihiatrie 2005 28. 8th World Congress of Biological Psychiatry,Vienna, jul 2005 29. 13 th WPA International Congress, Cairo, 10-15 sept 2005 30. Students and Young Doctors 1st European Congress of Military Medicine, Bucharest, oct. 2005 31. 18th ECNP Congress, Amsterdam, 22-26 oct. 2005 32. 11th Congress of Balcan Military Committee, Athens, june 18-22, 2006 33. 19th ECNP Congress, 16-20 sep 2006, Paris 34. 15th European Congress of Psychiatry, Madrid, Spain, March 17-21, 2007. 35. American Psychiatric Association 160th Annual Meeting „Addressing Patient Needs: Access, Parity and Human Care”, San Diego, may 19-24, 2007

8

36. 39th International Danube Symposium for Neurological Sciences and Continuing Education in conjunction with the 1st International Congress on ADHD from childhood to adult disease, 2-5 june 2007, Wurzburg 37. Forumul de Psihiatrie 2007, Bucuresti, 21-23 iunie 2007 38. '8th International Psychiatry Forum - Mind Matters Organised by sanofi-aventis' Bucharest, 22-23 June 2007 Bucharest. 39. 12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov 40. The 20th ECNP Congress, 13-17 oct 2007, Vienna, Austria 41. Astra Zeneca Neuroscience Academy 16-18 nov 2007, Bruxelles 42. An international meeting of minds supported by AstraZeneca Meet-the-Expert Workshop, 3-5 March 2008 Athens, Greece 43. American Psychiatric Association 161st Annual Meeting, Washington, 03-08 may 2008 44. 13th Congress of BMMC, 1-5 june 2008, Kusadasi 45. XXVI CINP Congress, 13-17 july, Munich, Germany 46. 12th EFNS Congress, Madrid, Spain, 23-26 aug, 2008 47. 21’st Congress of the European College of Neuropsychopharmacology, 30 aug – 03 sep 2008, Barcelona, Spain 48. XIV World Congress of Psychiatry, 20-25 sep 2008, Praga 49. „Living with bipolar disorder: symptom control and beyond” – an international meeting of minds sponsored by AstraZeneca Neuroscience, 27-29april 2009, Stockholm, Suedia 50. American Psychiatric Association 162nd Annual Meeting, „Shaping our future: science and service”, San Francisco 16-21 may 2009 51. 9th World Congress of Biological Psychiatry, 28 june-2 july 2009, Paris, France. 52. Simpozionul regional „Optiuni terapeutice actuale in tratamentul schizofreniei si al depresiei”, Bucuresti, 10, 16 iulie 2009 53. „Preceptorship Programme on Alzheimer’s Disease”, Alzheimer Center at the VU University Medical Center, 6 nov 2009 Amsterdam, Netherlands

LUCRĂRI ŞTIINŢIFICE

ARTICOLE PUBLICATE ŞI COMUNICĂRI ŞTIINŢIFICE

1. Schizofrenia - sindrom pozitiv şi negativ - noi dimensiuni clinico-terapeuticeRev. de Medicinã Militarã, nr.3, pg.267-272,1995M.D.Gheorghe, D. Vasile, Arina Baloescu, Gabriela Grigorescu

2. Evaluãri multidimensionale prin imagisticã cerebralã în schizofrenieRev. de Medicinã Militarã, nr.1, pg.39-47,1996

9

M.D.Gheorghe, D. Vasile, Arina Baloescu, Gabriela Grigorescu

3. Serotonina - actualitãti în mediatia serotoninergicã - implicatii clinice si terapeutice Rev. de Medicinã Militarã, nr.2, pg.39-47,1996M.D.Gheorghe, Arina Baloescu, D. Vasile, R. Mihãitã

4. Semnificatia psihopatologicã a comportamentului autoagresiv la tineriAl 17 -lea Simpozion Danubian de Psihiatrie, Timisoara, 24-27 aprilie, 1996M.D. Gheorghe D. Vasile, Carmen Andreescu, Gabriela Grigorescu ,Arina Baloescu, I. Pascu

5. Depresia refractarã conotaţii terapeuticeAl 17 -lea Simpozion Danubian de Psihiatrie, Timisoara, 24-27 aprilie, 1996M.D. Gheorghe, D. Vasile, Carmen Andreescu, Gabriela Grigorescu

6. Conotatii psihopatologice ale comportamentului autoagresiv la tineriCongresul National de Toxicologie Clinica, Bucuresti, 13-15.11.1996, Vol. rez. pg.41.M.D.Gheorghe, Vasile D., Emilia Lungut, Gh. Clejan.

7. Interrelatii clinico-paraclinice in schizofrenia negativa Rev. de Medicina Militara, nr.3, 1996 ,pg.243-246 M.D.Gheorghe, D. Vasile, A.Baloescu, G.Grigorescu

8. Migrena. Actualitati privind fiziopatologia si criteriile de diagnostic Rev. de Medicina Militara, nr.4, 1996, pg. 325-333 M.D.Gheorghe, E. Lungut, D. Vasile

9. Schizofrenia-Sindrom pozitiv si negativ (Noi dimensiuni clinico-terapeutice)

Medicina Moderna, 1996, vol.III, nr.6, pg.293-295 M.D.Gheorghe, D.Vasile, A.Baloescu, G.Grigorescu

10.Utilizarea Haloperidolului la schizofrenii somalezi – particularitati posologice

Conferinta Nationala de Psihiatrie, Bucuresti, 24-25 oct 1997, vol. rez.p.75 D. Vasile, M.D. Gheorghe, E. Lungut, G. Grigorescu

11.Clinical-Therapeutical Aspects and Encountered with the local Schizophrenic Patients within the “Restore Hope” Somalia MissionCongresul de Medicinã Militarã Balcanicã, Sofia, mai 1997, Vol. rez.D. Vasile, M.D.Gheorghe

10

12.Clinical Features of Khat –intoxication Encountered in the Somali People3-rd Congress of Balkan Military Medical Committee, Athens, 10-13 May, 416,1998D. Vasile

13.Alcohol Neurotoxicity : electrophisiology-psychopathology3-rd Congress of Balkan Military Medical Committee, Athens, 10-13 May, 417,1998Emilia Lunguţ, D. Vasile

14.New Therapeuthical Approaches to the First Psychotic Episode in the Soldiers3-rd Congress of Balkan Military Medical Committee, Athens, 10-13 May, 136,1998M.D.Gheorghe, D. Vasile, S.Isacu

15.Serotoninergic Syndrome – a present complication in the psychiatric practice3-rd Congress of Balkan Military Medical Committee, Athens, 10-13 May, 430,1998M.D.Gheorghe, D. Vasile

16.Agenţii antipsihotici atipici – alternativă în tratamentul schizofrenieiRev. de Toxicologie şi Terapeutică, 3, pg.191, 1998D. Vasile

17.Socio-cultural paricularities of the self-aggressive behaviour in the soldiers3-rd Congress of Balkan Military Medical Committee, Athens, 10-13 May,

136,1998D. Vasile, Gabriela Grigorescu, M.D.Gheorghe

18.Therapeutical profile in refractory depressionBalkan Military Medical Review, Vol,1 nr.2: 169-172, 1998M.D.Gheorghe, D. Vasile, C. Andreescu, Gabriela Grigorescu

19.Suicidal attempt in the army- romanian experience 20th Congress of the International Association for Suicide Prevention, 6-10 nov 1999, Athens, Greece, Abstract Book p.125 M.D.Gheorghe, D. Vasile, A. Baloescu, G.Grigorescu

11

20.New Therapeutical Approaches of Heroin Withdrawal in Polysubstance Dependence

4th Congress of Balkan Military Medical Committee, Bucharest, June 6-10, Abstract Book, pg. 191, 1999

Vasile D., M.D.Gheorghe, V.Voicu

21.Restore Hope –Psychiatric Morbidity Structure and Some Peculiarities of Main Psychopathological Entities, 4th Congress of Balkan Military Medical Committee, Bucharest, June 6-10, Abstract Book, pg. 235, 1999Vasile D.

22.Evoked motor responses of the brain, spinal cord and roots – clinical aproach5th Congress of the Balkan Military Medical Committee Ankara, Turkey 25-28 sept. 2000- Volum abstract pag. 111E. Lunguţ, D. Vasile

23.The personality features among heroin withdrawal impatients5th Congress of the Balkan Military Medical Committee Ankara, Turkey 25-28 sept. 2000- Volum abstract pag. 144D. Vasile , M.D. Gheorghe

24.Comportamentul autoagresiv la tineri – caracteristici si management terapeutic

Psihiatria 2000, Congres national cu participare internationala, 4-7 oct 2000, Iasi D. Vasile, M.D. Gheorghe, G. Grigorescu, A. Baloescu

25.Abordări terapeutice în sevrajul la opioideRevista Durerea acută şi cronică, Vol. 8 nr. 2/2000 pag. 56D. Vasile, M. Stoenescu

26.Cholinergic therapies used for improving cognitive deficit in Alzheimer disease Alzheimer Europe 11th Conference June 10th – 12th 2001, Bucharest,

RomaniaD. Vasile, M.D. Gheorghe

27.Zyprexa in the treatment of behavioral symptoms in dementia7th World Congress of Biological Psychiatry – 1-6 July 2001 Berlin, Germany- Volum abstract pag. 123M.D. Gheorghe, D.Vasile

12

28.Efficacy and tolerability of Solian in acute exacerbation of schizophrenia 7th World Congress of Biological Psychiatry – 1-6 July 2001 Berlin, Germany- Volum abstract pag. 301M.D. Gheorghe, D.Vasile

29.Rolul tomoscintigrafiei cerebrale de perfuzie in diagnosticul dementelorPrimul congres national de medicina nucleara cu participare internationala, Bucuresti, 03-06.10.2001-volum abstract, pag.58Adriana Petrescu, George Marinescu, D. Vasile

30.Fenomenul de recadere in consumul de heroina postsevrajConferinta Nationala « Terapie si management in psihiatrie », Craiova, 25-27.10.2001-Volum abstract, pag.81D. Vasile,R. Ciurea

31.Sindromul de sevraj la opiacee. Toxicomania si sarcinaRevista de Medicina Militara, nr.2/2001,pag.239D. Vasile, M. Stoenescu, A.Vasilache

32.Electrodiagnosis of diabetic neuropathy (VCM,VCS, F wave and H reflex)6th Congress of Balkan Military Medical Committee, Plovdiv, Bulgaria, 01-03.10.2001, vol.abstract. pag.21E. Lungut, D.Vasile

33.Heroin dependence- personality disorder, a dual diagnosis increasing treatment costsThird Regional Meeting, Financing Mental and Addictive Disorders in Central and Eastern Europe, Bucharest, November 23-25, 2001, vol. Abstract. Pag.22D. Vasile, M.D. Gheorghe

34.Stimularea nervului vag – aplicatii in depresia refractara la tratament Revista Romana de Psihiatrie, seria III, vol. III, nr.1-2, 2001, pg.49-53 D. Vasile, M.D.Gheorghe, R. Ciurea, C.Tudor

35.Tratamentul farmacologic al dependentei de heroinaRevista Romana de Psihiatrie, seria III, vol. III, nr.3-4, 2001, pg.170-174D. Vasile, M.D. Gheorghe, R. Ciurea, Corina Tudor

36.Early pharmacological intervention in first episode schizophreniaAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-21,2002, Volum abstract,pag.34

13

D. Vasile

37.Reboxetine in the treatment of elderly inpatients with Major Depressive DisorderAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-

21,2002-volum abstract, pag.41D. Vasile,O. Vasiliu,A. Baloescu

38.Efficacy of venlafaxine in the treatment of generalized anxiety disorderAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-21,2002,

vol. abstract pag.56D. Vasile, R. Ciurea, A.Baloescu

39.Efficacy of Rivastigmine on cognitive and behavioural symptoms in patients with Alzheimer’s diseaseAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-21,2002,

pag.58Baloescu, C. Tudor, D.Vasile

40.Heroin-consuming relapse after detoxificationAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-21,2002,

pag.61D. Vasile,R. Ciurea, M.D. Gheorghe

41.Adenosine’s influences on different phases of memorisation processesAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-21,2002

pag.66S. Stoleru, T. Raducanu, D. Vasile

42.The effects of adenosinic agonists and antagonists on behaviour and on EEG activity in ratsAbstracts of the 7th Regional Meeting of ECNP, Bucharest, April 19-21,2002,

pag.67Cristescu, T. Raducanu, D. Vasile

43.Abordari terapeutice in dependenta de heroina5th Xenobiotic Metabolism and Toxicity Workshop of Balkan Countries, Constanta, 29.05-01.06.2002, vol. Abstract. Pag.7D. Vasile

44.Venlafaxina in tratamentul tulburarii de anxietate generalizataRevista de Terapeutica, Farmacologie si Toxicologie clinica, nr. 1, martie 2002, pag.136D. Vasile, R. Ciurea

14

45.Borderline personality- heroin dependence comorbidityXII World Congress of Psychiatry, 24-29.08.2002, Yokohama, Japan, vol.

Abstract. Pag.38D. Vasile, M.D.Gheorghe, R. Ciurea

46.The efficacy of donepezil in Alzheimer’s disease cognitive deficitAbstracts of the 15th Congress of the European College of Neuropsychopharmacology, Barcelona, Spain, October 5-9, 2002, S374D. Vasile, M.D. Gheorghe.

47.Antisocial personality disorder- heroin dependence comorbidityAbstracts of the 15 th Congress of the European College of Neuropsychopharmacology, Barcelona, Spain, October 5-9, 2002 , S392.D. Vasile, M.D. Gheorghe, R. Ciurea, S. Paraschiv

48.Comparative Analysis of the Antipsychotics Side Effects in the Onset of Schizophrenia in ConscriptsD.Vasile, O.Vasiliu, S.Paraschiv, C.A.Sirbu, M.D.Gheorghe“Balkan Military Medical Review”, 2002, 5 (1-2):24-29

49.Imaging contribution in long term monitoring of cerebral hydatosisC.A. Sîrbu, D. Vasile, F. Cristea, R. Munteanu, C. Constantin, D. Constantin“Balkan Military Medical Review”, 2002, 5 (1-2): 63-71

50. O noua abordare terapeutica in durerea cronica: mirtazapina D. Vasile, M.R.Stoenescu „Durerea”-Buletin informativ al Asociatiei Romane pentru Studiul Durerii, vol.XII, nr.1,2002, pg.11-13

51.Utilizarea Exelonului în ameliorarea deficitului cognitiv în Boala AlzheimerAEP Spring Symposium, Roma , april 24-26, 2003D.Vasile, R. Ciurea, M.D.Gheorghe

52.The evaluation of personality disorders in soldiers with self-injuring behavior"8th Congress of Balkan Military Medical Committee", Cluj, 2003O Vasiliu, D. Vasile

53.Trazodone as an optimal treatment for the sexual disfunctions in depressed patients8th Congress of BMMC", Cluj, 2003

15

O Vasiliu, D. Vasile

54. Efficacy of the mirtazapine treatment in the neoplasm associated pain"8th Congress of BMMC", Cluj, 2003D. Vasile, O Vasiliu

55.Treatment of neoplasm secondary depression using mirtazapine"8th Congress of BMMC", Cluj, 2003D. Vasile, O Vasiliu

56.The importance of the family background in heroin-dependence primary and secondary prophylaxis"8th Congress of BMMC", Cluj, 2003D. Vasile, O Vasiliu

57.Weight gain as a secondary effect in typical and atypical antipsychotic treatment of schizophrenia"8th Congress of BMMC", Cluj, 2003D. Vasile, O Vasiliu

58.Cardiovascular side effects caused by the administration of atypical antipsychotics"8th Congress of BMMC", Cluj, 2003D. Vasile, O Vasiliu

59.The onset of action of mirtazapine in a group of military personnell8th Congress of BMMC, Cluj, 2003D. Vasile, O Vasiliu

60.The efficacy of reboxetine in the treatment of inhibited depression8th Congress of BMMC Cluj, 2003D. Vasile, O Vasiliu

61.Trazodone in sexual dysfunctions of depressed patients receiving selective serotonin reuptake inhibitorsWPA International Congres, Florenta, noiembrie, 2004D. Vasile, O Vasiliu

62.Sexual dysfunctions in patients with depression treated with SSRI: A therapeutic approach

European Psychiatry, 12th AEP Congress, Geneva, 14-18 apr 2004, vol.19, suppl.1, p.215s D. Vasile, M. Gheorghe, O. Vasiliu

16

63.The effect of atypical antipsychotics on depressive symptomatology in schizophrenia17th ECNP Congress, Stockholm, octombrie, 2004D. Vasile, O Vasiliu

64.Drug monitoring factors in schizophrenia treatment17th ECNP Congress, Stockholm, octombrie, 2004D. Vasile, O Vasiliu

65.Atypical antipsychotics- Side effects profileInternational Congress of Biological Psychiatry, Sydney, 2004D. Vasile, O Vasiliu

66.Noncompliance factors in schizophrenia treatment9th Congress of BMMC, Antalya, 2004D. Vasile, O Vasiliu

67.The importance of self image distorsions in depressive disorders with suicidal attempts9th Congress of BMMC", Antalya, 2004D. Vasile, O Vasiliu

68.Defense mechanisms in patients with oncological pathology9th Congress of BMMC, Antalya, 2004O Vasiliu , D. Vasile

69.Sleep quality improvement in depressed patients receiving Trazodone9th Congress of BMMC", Antalya, 2004D. Vasile, O Vasiliu

70.Multiaxial diagnosis and quality of life assessment in Alzheimer disease9th Congress of BMMC", Antalya, 2004D. Vasile, O. Vasiliu

71.Improvement of depressive symptomatology in the onset of schizophrenia9th Congress of BMMC", Antalya, 2004D. Vasile, O Vasiliu

72.Demographic data analysis in heroin dependence patients9th Congress of BMMC", Antalya, 2004D. Vasile, O. Vasiliu

17

73.Correlation between personality features and adjustment disorders in conscripts9th Congress of BMMC", Antalya, 2004D. Vasile, O. Vasiliu

74.Efectul medicatiei psihotrope asupra intervalului QTcTerapeutica, Farmacologie si Toxicologie Clinica vol VIII, nr.2, Bucuresti, 2004, Ed.Rp. SRLD.Vasile, O.Vasiliu, S.Paraschiv, E. Lungut, A. Apetroaei

75.Antidepresivele cu mecanism dual versus SSRI in terapia tulburarilor depresiveD.Vasile, M. Gheorghe, O.Vasiliu, A. Apetroaei“Jurnalul Roman de Psihofarmacologie”, vol.4, nr.1,2, 2004, Editura Medicala Universitara Craiova

76.Implicatiile neurobiologice si farmacoclinice ale efectului placebo “Jurnalul Roman de Psihofarmacologie” , vol.4, nr.1,2, 2004, Editura Medicala Universitara CraiovaD.Vasile, M.Gheorghe, A. Apetroaei, O.Vasiliu

77.Factorii deciziei terapeutice- de la experienta clinica la studiile farmacologiceD. Vasile, M.D.Gheorghe, O.Vasiliu, S.Paraschiv„Terapeutică, farmacologie şi toxicologie clinică”, vol.VIII, nr.4, Bucureşti, 2004, Ed.Rp. SRL

78.Actualitati neurobiologice si farmacoclinice in dementa AlzheimerD.Vasile, M.D.Gheorghe, O.Vasiliu, A.Apetroaei“Stetoscop”, Editura Anteus, nr.38, 2005.

79.Atypical antipsychotics agents in acute psychotic disorder with affective features

D. Vasile, O.Vasiliu, M. Gheorghe The world journal of biological psychiatry vol.6, suppl.1, 8th World Congress of Biological Psychiatry,Vienna, jul 2005 , p.320 80.The effectiveness of intravenous Trittico in Major Depresive Episode M. Gheorghe, D. Vasile, O.Vasiliu The world journal of biological psychiatry vol.6, suppl.1, 8th World Congress of Biological Psychiatry,Vienna, jul 2005 , p.179

18

81.Treatment in Alzheimer dementia with depressed mood D. Vasile, O. Vasiliu, A. Apetroaei, S. Paraschiv, M.D. GheorgheXIII World Congress of Psychiatry, Cairo, September, 10-15, p. 532, 2005

82.Efficacy, safety and compliance in the long acting atypical anipsychotic treatmentM.D.Gheorghe, D. Vasile, G. GrigorescuXIII World Congress of Psychiatry, Cairo, September, 10-15, p. 716, 2005

83.The efficacy of bupropion in alcohol dependent patients with major depressive episodeD. Vasile, M.D. Gheorghe, O. VasiliuEuropean Neuropsychopharmacology, 18th ECNP Congress, Amsterdam, The Netherlands, October, 22-26, S 400, 2005

84.Parenteral administration of olanzapine for schizophrenic with agressive behaviourD. Vasile, M.D. Gheorghe, O. Vasiliu, A. BaloescuEuropean Neuropsychopharmacology, 18th ECNP Congress, Amsterdam, The Netherlands, October, 22-26, S 466, 2005

85.Psychotropic drugs discontinuation syndromes in clinical practiceD. Vasile, O. Vasiliu, M.D.Gheorghe, P. Ivanov, D. Ojog DBalkan Military Medical Review, 9, January, 38-41, 2006

86.Nonbenzodiazepine and benzodiazepine hypnotic comparative analysis in organic conditions secondary insomnia

Vasile D., Vasiliu O., Ojog D., Sarmache M.,Vasile M.,Paraschiv S. The journal of the Association of European Psychiatrists, 14th AEP Congress, Nice, 4-8 march 2006, S152

87.Effectiveness of cognitive behavioural therapy in dual diagnosis: panic disorder and major depressive disorder

Vasile D., Vasiliu O., Ivanov P., Paraschiv S. The journal of the Association of European Psychiatrists, 14th AEP Congress, Nice, 4-8 march 2006, S152

88.Comorbidity association study in heroin dependent patients Vasile D., Vasiliu O., Ivanov P., Varzaru C., Ojog D., Paraschiv S. The journal of the Association of European Psychiatrists, 14th AEP Congress, Nice, 4-8 march 2006, S144

89.Bupropion as craving decreasing agent in alcohol dependent patients

19

Vasile D., Vasiliu O., Gheorghe M.D., Ivanov P., Paraschiv S. 11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens

90.Depressive symptomatology cluster analysis Vasile D., Vasiliu O., Vasile M., Ojog D.

11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens

91.Defense mechanism analysis in conscripts diagnosed with adjustment disordersVasiliu O, Vasile D, Varzaru C, Ojog D.11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p. 100

92.Coping mechanism as prognosis factors in the cognitive behaviour therapy of major depressive disorderVasiliu O, Vasile D, Varzaru C, Ojog D.11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p. 98

93.Psychotherapeutical crisis interventions in depressive disorders with suicidal ideationVasiliu O, Vasile D, Ivanov P, Paraschiv S.11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p.33

94.Determination of quetiapine in urine samples by GC-MS methodIonica M, Macovei R, Vasile D, Caragea D, Forje M.11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p.104

95.Aripiprazole efficacy in chronic schizophrenia with prominent negative symptomsVasile D., Vasiliu O, Gheorghe M.D.11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p.85

96.Augmenting antidepressive psychopharmacological approach with cognitive-behavioral therapy in refractory major depressive disorderVasiliu O, Vasile D, Sarmache M., Vasile M.11th Congress of Balkan Military Medical Committee, June 18-22, 2006, Athens, p. 89

20

97.Bupropion efficacy in major depressive disorder and alcohol dependence dual diagnosisVasile D., M. Sarmache, M.L. Vasile, M.D.GheorgheEuropean Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September, 2006, S292

98.Antidepressant switch efficacy in selective serotonin reuptake inhibitors resistant major depressive disorderVasiliu O, Vasile D, Miclos M, Ivanov PEuropean Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September, 2006, S324

99.Amisulpride association to selective serotonin reuptake inhibitors in severe major depressive episodes with psychotic featuresVasiliu O, Vasile D, Paraschiv S, M. Miclos, Ivanov P.European Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September, 2006, S362

100. Side effects of atypical antipsychotics – prediction for factor for complianceBaloescu A, Vasile D,.Gheorghe M.D, Grigorescu G.European Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September, 2006, S404

101. Negative and cognitive syptomatology improvement during aripiprazole treatment in chronic schizophreniaGheorghe M.D., Voicu V.A., Vasile D., Vasiliu O.European Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September, 2006, S409

102. Risperidone long acting im formulation in high risk of noncompliance bipolar patientsVasile D, Vasiliu O, Ojog D, Gheorghe M.D.European Neuropsychopharmacology, 19th ECNP Congress Paris, France, 16-20 September, 2006, S413

103. Managementul farmacoterapeutic al pacientilor psihotici agresiviVasile D., Vasiliu O, Sarmache M, Vasile M.Terapie si management in psihiatrie, 28 septembrie – 1 octombrie, 2006, Craiova, p.27-28

104. Comorbiditati addictive in tulburarea de panica

21

Vasiliu O, Vasile D, Ojog D.Terapie si management in psihiatrie, 28 septembrie – 1 octombrie, 2006, Craiova, p.120-121

105. Evaluarea calitatii vietii la pacientii cu dementa vasculara Vasile D, Vasiliu O, Varzaru C, Ivanov P.

Terapie si management in psihiatrie, 28 septembrie – 1 octombrie, 2006, Craiova, p.132-133

106. Prim episod schizofrenic – Evaluare SPECT cerebrala de perfuzie pre si post-tratament cu antipsihotice atipiceRimbu A., Marinescu G, Mititelu R, Ghita S, Mazilu C, Vasile D, Baloescu A, Tudor C, Isacu S, Vasiliu O, Gheorghe M.D, Codorean I.Al 2-lea Congres National de Medicina Nucleara 8-11.11.2006, Bucuresti, p.110-111

107. Metabolic adverse events of antipsychotic treatment in chronic schizophrenia

D. Vasile, O. Vasiliu, S. Paraschiv, P. Ivanov, M. Terpan, M. Vasile European Psychiatry, 15th AEP Congress, 17-21 mar 2007, Madrid, S170-S171

108. Venlafaxine XR versus fluoxetine in the treatment of major depressive disorder and generalized anxiety disorder dual diagnosis

D. Vasile, O. Vasiliu, P. Ivanov, D. Ojog, M. Sarmache, M. Vasile European Psychiatry, 15th AEP Congress, 17-21 mar 2007, Madrid, S247 109. Augmenting antidepressant psychopharmacological approach with

cognitive-behavioural therapy in bipolar depression D. Vasile, O. Vasiliu, D. Ojog, M. Vasile, M.Sarmache, M.Terpan

European Psychiatry, 15th AEP Congress, 17-21 mar 2007, Madrid, S261

110. Nonbenzodiazepine versus benzodiazepine hypnotic eficiency in older people D. Vasile, O. Vasiliu, M. Vasile, M.Sarmache, M.Terpan

European Psychiatry, 15th AEP Congress, 17-21 mar 2007, Madrid, S289

111. Augmenting psychopharmacological treatment with cognitive-

behavioural therapy in major depressive disorder and alcohol dependence dual diagnosisD. Vasile, O. Vasiliu, M.Sarmache, M.Terpan, D. Ojog

22

39th International Danube Symposium for Neurological Sciences and Continuing Education in conjunction with the 1st International Congress on ADHD from childhood to adult disease, 2-5 june 2007, Wurzburg

112. Intramuscular olanzapine efficiency in the acute treatment of schizoaffective disorderD. Vasile, O. Vasiliu, S. Paraschiv, M. Vasile, R. Brisculescu39th International Danube Symposium for Neurological Sciences and Continuing Education in conjunction with the 1st International Congress on ADHD from childhood to adult disease, 2-5 june 2007, Wurzburg

113. Compliance Therapy as Increasing Adherence Method for Alcohol Addiction

D. Vasile, O.Vasiliu, S.Paraschiv, M. Terpan12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

114. New methods for mood disorders treatmentD. Vasile, O. Vasiliu12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

115. Ethiological considerations over delirium due to general medical conditions

D. Vasile, O.Vasiliu, M. Vasile, M. Sarmache12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

116. Comparative analysis of second generation antipsychotics in the treatment of negative symptoms in chronic schizophrenia

D. Vasile, O. Vasiliu, S. Paraschiv, M. Terpan12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

117. Bupropion administration in major depressive with alcohol dependence dual diagnosis

D. Vasile, O.Vasiliu, D. Ojog, M.Terpan12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

118. Aripiprazole administration in schizoaffective disorder, bipolar typeD. Vasile, O. Vasiliu, M. Sarmache, M. Vasile12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

119. Anxiety disorders screening in general internal medicine clinic hospitalised patients

D. Vasile, O. Vasiliu, R. Brisculescu, D. Ojog12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

23

120. Cognitive behavioural therapy in generalised anxiety disorderO. Vasiliu, D. Vasile, M. Vasile, M. Sarmache12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

121. Defense mechanisms analysis in somatoform disordersO. Vasiliu, D. Vasile, R. Brisculescu, D. Ojog12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

122. Hypothyroidism presenting as psychosis: „mixedema madness” case report

C. Spiroiu, A.E.Ranetti, A. Mazilu, D. Vasile, C.Tudor, O.Vasiliu.12th Congress of BMMC, 24-28 iunie 2007, Poiana Brasov

123. Intramuscular and orodispersable olanzapine efficiency in the acute treatment of manic episodes

D. Vasile, O. Vasiliu, S. Paraschiv, M. Vasile, M. Terpan European Neuropsychopharmacology, The 20th ECNP Congress, 13-17 oct 2007, Vienna, Austria, pg. S430

124. Combined atypical antipsychotics and valproate sodium approach in the bipolar I disorder maintenance treatment

D. Vasile, O. Vasiliu, M. Miclos, P. Ivanov, M. Sarmache European Neuropsychopharmacology, The 20th ECNP Congress, 13-17 oct 2007, Vienna, Austria, pg. S431

125. Combined antidepressants and quetiapine therapy in bipolar depression with psychotic features- an open label study

D. Vasile, O. Vasiliu, S. Paraschiv, D. Ojog, M. VasileEuropean Neuropsychopharmacology, The 20th ECNP Congress, 13-17

oct 2007, Vienna, Austria, pg. S487

126. Combined pregabalin and selective serotonin reuptake inhibitors in adjustement disorders with anxiety

D. Vasile, O. Vasiliu, P. Ivanov, M. Sarmache, M. TerpanEuropean Neuropsychopharmacology, The 20th ECNP Congress, 13-17

oct 2007, Vienna, Austria, pg. S517

127. Alteration of body image perception as a side event of antipsychotic treatment in schizophrenic patients

D.Vasile, O.Vasiliu, P.Ivanov, M.Terpan, I. ParaicoThe 16th AEP European Congress of Psychiatry, Nice, April 5 – 9, 2008

24

128. Improving the quality of life in patients with malignant tumors using cognitive psychotherapy

D.Vasile, O.Vasiliu, M.Vasile, M.SarmacheThe 16th AEP European Congress of Psychiatry, Nice, April 5 – 9, 2008

129. Coping mechanisms evaluation in chronic schizophrenic patientsD.Vasile, O.Vasiliu, M.Vasile, M. Terpan, I. ParaicoThe 16th AEP European Congress of Psychiatry, Nice, April 5 – 9, 2008

130. Alzheimer dementia associated cognitive and non-cognitive symptoms evolution during donepezil treatment

D.Vasile, O.VasiliuThe 16th AEP European Congress of Psychiatry, Nice, April 5 – 9, 2008

131. Cognitive-behavioral therapy efficacy in major depressive disorder and histrionic personality disorder dual diagnosis

D.Vasile, O.Vasiliu, D.Ojog, R. Brisculescu, M. VasileThe 16th AEP European Congress of Psychiatry, Nice, April 5 – 9, 2008

132. Oral risperidone efficacy in Alzheimer dementia with psychotic features D. Vasile, O. Vasiliu, D. Patriche, B. Stanescu, R. Bancescu The International Journal of Neuropsychopharmacology, XXVI CINP Congress, Munich,13-17 july 2008, p.176

133. Bupropion SR augmentation strategy in mirtazapine major depressive disorder incomplete responders D. Vasile, O. Vasiliu, M. Vasile, O. Cretu, D. Ojog The International Journal of Neuropsychopharmacology, XXVI CINP Congress, Munich,13-17 july 2008, p.197

134.Serotoninergic combos in treatment resistant depressive disorder D. Vasile, O. Vasiliu, M. Vasile, O. Cretu, M. Terpan The International Journal of Neuropsychopharmacology, XXVI CINP Congress, Munich,13-17 july 2008, p.207

135.The switch on trazodone in major depressive disorder with significant weight gain D. Vasile, O. Vasiliu, M. Vasile, O. Cretu, D. Ojog The International Journal of Neuropsychopharmacology, XXVI CINP Congress, Munich,13-17 july 2008, p.207

25

136.The efficacy of venlafaxine vs. SSRIs in panic disorder and major depressive disorder dual diagnosis D. Vasile, O. Vasiliu, B. Stanescu, R. Bancescu, M. Terpan The International Journal of Neuropsychopharmacology, XXVI CINP Congress, Munich,13-17 july 2008, p.284

137.Efficacy of tianeptine in the treatment of post-stroke depression D. Vasile, O. Vasiliu, O. Cretu, D. Patriche, B. Stanescu, R. Bancescu 12th Congress of the European Federation of Neurological Societes, Madrid, 23-26 aug 2008

138.Therapeutic management of interictal dysphoria in epilepsy D. Vasile, O. Vasiliu, P. Ivanov, B. Stanescu, M. Terpan, R. Bancescu 12th Congress of the European Federation of Neurological Societes, Madrid, 23-26 aug 2008

139.Atypical antipsychotics in the treatment of non-cognitive symptoms of Alzheimer dementia D. Vasile, O. Vasiliu, P. Ivanov, M. Terpan, D. Patriche, D. Ojog

12th Congress of the European Federation of Neurological Societes, Madrid, 23-26 aug 2008

140.Selective serotonin reuptake inhibitors efficacy in the treatment of multiple sclerosis associated with depressive disorder

D. Vasile, O. Vasiliu, M. Vasile, D. Patriche, B. Stanescu, R. Bancescu12th Congress of the European Federation of Neurological Societes,

Madrid, 23-26 aug 2008

141.Therapeutic management of cognitive symptoms in Parkinson’s disease dementia using rivastigmine

D. Vasile, O. Vasiliu, M. Vasile, O. Cretu, P. Ivanov, D. Ojog12th Congress of the European Federation of Neurological Societes,

Madrid, 23-26 aug 2008

142.An open study of the safety and efficacy of a novel antipsychotic (BL-1020) with reduced risk for extrapyramidal symptoms

R. Anand, M. Davidson, Y. Geffen, D. Vasile, I. DanEuropean Neuropsychopharmacology, 21st ECNP Congress, 30 aug-3 sep

2008, Barcelona, S425

143.Cognitive-behavioural therapy and antidepressant drug treatment in irritable bowel syndrome

D. Vasile, O. Vasiliu, D. Patriche, P.Ivanov, B. Stanescu

26

Journal of Czech and Slovak Psychiatry, vol.104,suppl.2, XIV World Congress of Psychiatry, 20-25 sep 2008, Prague, p.933

144.The influence of coping mechanisms over the evolution of acute stress disorder

D. Vasile, O. Vasiliu, M. Vasile, D. Patriche, D. OjogJournal of Czech and Slovak Psychiatry, vol.104,suppl.2, XIV World

Congress of Psychiatry, 20-25 sep 2008, Prague, p.1145

145.Crisis therapy intervention in panic disorderD. Vasile, O. Vasiliu, M. Vasile, O. Cretu, M. TerpanJournal of Czech and Slovak Psychiatry, vol.104,suppl.2, XIV World

Congress of Psychiatry, 20-25 sep 2008, Prague, p.1235

146.Guided imagery applications in breast cancer related mixed anxious-depressive disorder

D. Vasile, O. Vasiliu, M. Vasile, M. Terpan, D. OjogJournal of Czech and Slovak Psychiatry, vol.104,suppl.2, XIV World

Congress of Psychiatry, 20-25 sep 2008, Prague, p.1461

147.The management of alcoholism dependence in patients with oncologic disease

D. Vasile, O. Vasiliu, O. Cretu, P.Ivanov, B. StanescuJournal of Czech and Slovak Psychiatry, vol.104,suppl.2, XIV World

Congress of Psychiatry, 20-25 sep 2008, Prague, p.1461

148. Evaluarea comorbiditatilor psihiatrice in tulburarile somatoforme„Rev. de Medicina Militara”, CXI, nr.2/2008, pg.3-8D.Vasile, O.Vasiliu

149.Evaluarea profilului terapeutic in adictii„Rev. de Medicina Militara”, CXI, nr.2/2008, pg.36-43O.Vasiliu, D.Vasile, N.Mitrofan

150.Implicatii clinice ale noilor mijloace de evaluare terapeutica in adictii„Rev. de Medicina Militara”, CXI, nr.2/2008, pg.51-60O.Vasiliu, D.Vasile, N.Mitrofan

151.Terapia depresiei la pacientii oncologici„Medicina Moderna”, vol.XV-nr.8-2008, pg.407-412D.Vasile, O.Vasiliu, O.Cretu, B.Stanescu, E.Badescu, R.Bancescu,

M.Terpan

27

152.Actualitati si perspective in terapia farmacologica a tulburarilor de anxietate

„Medicina Moderna”, vol.XV-nr.9-2008,pg.488-492D.Vasile, O.Vasiliu, M.Vasile, D.Patriche, A.Banica

153.Rolul receptorilor N-metil-D-aspartat in psihofarmacologia tulburarilor afective

„Therapeutics, pharmacology and clinical toxicology”, vol.XII, nr.3, sep.2008, pg.349-353

D.Vasile, O.Vasiliu, M.Vasile, O.Cretu

154.Administrarea risperidonei cu actiune prelungita la pacientii non-complianti cu tulburare bipolara I

„Therapeutics, pharmacology and clinical toxicology”, vol.XII, nr.4, dec.2008, pg.489-492

D.Vasile, O.Vasiliu, D.Ojog

155.Atipical side effects of antipsychotics – risc factor for noncompliance in first episode of schizophrenia 9th World congress of Biological Psychiatry, The World Journal of Biological Psychiatry, vol.10-supplement 1-2009, pg.281

R. Grigorescu, V. Voicu, D. Vasile, G. Grigorescu

156.Cognitive impairment profile in schizophrenia9th World congress of Biological Psychiatry, The World Journal of

Biological Psychiatry, vol.10-supplement 1-2009, pg.281-282G. Grigorescu, D. Vasile, C. Tudor, R. Grigorescu

157. Efficacy of aripiprazole vs. quetiapine for the treatment of hostility in acute patients with schizophrenia

9th World congress of Biological Psychiatry, The World Journal of Biological Psychiatry, vol.10-supplement 1-2009, pg.282

D. Vasile, G. Grigorescu, C. Tudor, O. Vasiliu, R. Grigorescu158.Duloxetine versus escitalopram in the treatment of major depressive disorder and generalized anxiety disorder dual diagnosis

9th World congress of Biological Psychiatry, The World Journal of Biological Psychiatry, vol.10-supplement 1-2009, pg.384

D. Vasile, O. Vasiliu, M. Vasile, G. Grigorescu, M. Terpan

159.Milnacipran efficacy in major depressive disorder and alcohol dependence dual diagnosis

9th World congress of Biological Psychiatry, The World Journal of Biological Psychiatry, vol.10-supplement 1-2009, pg.384

28

D. Vasile, O. Vasiliu

160.Tianeptine efficacy in the treatment of multiple sclerosis associated anxiety disorder

9th World congress of Biological Psychiatry, The World Journal of Biological Psychiatry, vol.10-supplement 1-2009, pg.385

D. Vasile, V. Voicu.

161. Evaluarea mecanismelor defensive la pacientii cu dublu diagnostic-fibromialgie si tulburare mixta depresiv-anxioasaD.Vasile, O.Vasiliu, A.G.Mangalagiu, M.L.Vasile, G.Grigorescu, B.Vasile, M.Terpan, B.M.Petrescu, D.M.Năstase Revista de Medicină Militară 2010; 2 (CXIII): 43-47

162. Abordari psihofarmacologice ale sistemului melatoninergic in tulburarile hipniceD.Vasile, O.Vasiliu, A.G.Mangalagiu, D.M.Nastase, B.Vasile, E.Badescu, M.Vasile, M.TerpanRevista de Medicină Militară 2010; 1 (CXIII): 44-51

163. Dictionar de psihiatrie- AlogiaD.Vasile, O.Vasiliu

Revista de Medicină Militară 2010; 4 (CXIII): 22

164. Abordari psihofarmacologice in preventia secundara a stresului posttraumaticD.Vasile, O.Vasiliu, A.G.Mangalagiu, D.Ungureanu, B.Vasile, M.Vasile, D.M.NastaseRevista de Medicină Militară 2010; 4 (CXIII): 23-32

165. Aspecte cultural-istorice ale consumului de substanţe psihoactive O.Vasiliu, D.Vasile Revista de Medicină Militară 2011; 2 (CXIV): 33-39

166. 25 years of fluoxetine: how far are we from an optimal treatment for depression?N.F.Taina, D.Vasile, O.Vasiliu, A.G.Mangalagiu, B.StanescuTherapeutics, Pharmacology and Clinical Toxicology, 2011;XV(Suppl.II):74

167. Nightmare pharmacologic treatment in posttraumatic stress disorder-a systematic literature reviewN.F.Taina, D.Vasile, O.Vasiliu, A.G.Mangalagiu, A.Banica, D.G.OjogTherapeutics, Pharmacology and Clinical Toxicology, 2011;XV(Suppl.II):74

29

168. Analiza eficacităţii medicaţiei psihotrope în coşmarurile asociate tulburării de stres posttraumaticO.Vasiliu, D.Vasile, NF Taină, AG Mangalagiu, A BănicăRevista de Medicină Militară 2011; 3 (CXIV): 31-38.

169. Dictionar de psihiatrie- AnhedoniaD.Vasile, O.Vasiliu,Revista de Medicină Militară 2011; 3 (CXIV): 24

170. Analiza eficacitatii terapeutice a duloxetinei comparativ cu inhibitorii selectivi ai recaptării serotoninei în depresia majoră recurentă cu manifestări atipiceV.Daniel, Vasiliu O, Ungureanu Daniela, Tudor Corina, Bogdan V, Mangalagiu AG, Banica Anisoara, Grosu Georgeta, Meliaca A.Revista de Medicina Militara 2011; CXIV (Suppl):24

171. Evaluation of the mood-stabilizers associated neurocognitive effects in bipolar patientsD.Vasile, O.Vasiliu, A.G.Mangalagiu, D.G.Ojog,

Therapeutics, Pharmacology and Clinical Toxicology 2011;XV(4):304-308

172. Comparative analysis of dual serotoninergic and noradrenergic antidepressants in double depression with alcohol dependenceD.Vasile, O.Vasiliu, A.G.Mangalagiu, G.A.Sopterean, R.E.BratuRomanian Journal of Psychopharmacology 2013;13(1):7-15

173. The Efficacy of dual action antidepressants in depressive disorder associated with systematic lupus erythematosusC.Tudor, O.Vasiliu, M.Zavoianu, G.Grigorescu, A.G.Mangalagiu, D.Vasile, O.MagazinRomanian Journal of Psychiatry 2013; XV (Suppl.1):P-51

174. Newly diagnosed Alzheimer Dementia cases in non-psychiatric departments of a general medical hospital- a liaison psychiatry studyD. Vasile, O.Vasiliu, A.G.Mangalagiu, M.Blandu, B.M.PetrescuRomanian Journal of Psychiatry 2013; XV (Suppl.1):P-69

175. Analysis of the organic comorbidities in early-onset Alzheimer Dementia patientsD.Vasile, O.Vasiliu, A.G.Mangalagiu, B.M.Petrescu, M.Blandu

Romanian Journal of Psychiatry 2013; XV (Suppl.1)

30

176. Evolution of addictive comorbidities in a group of patients diagnosed with schizophrenia during atypical antipsychotic treatmentD.Vasile, R.A. Macovei, O.Vasiliu, A.G.Mangalagiu, C.Tudor, European Psychiatry 2013;28(1):1127

177. Cognitive-behavioral therapy efficacy in major depression with associated axis II risk factor for negative prognosisD.Vasile, O.Vasiliu, Recent Advances in Risk Management, Assessment and Mitigation, 2010, 460-464

178. Quality of life changes through risk factors reduction focused psychotherapy in cancer diagnosed patientsD.Vasile, O.Vasiliu, D.G.Ojog, D.Vasile, O.Vasiliu, Recent Advances in Risk Management, Assessment and Mitigation, 2010, 464-467

179. Burn-out in a sample of physicians, nurses and medical students- risk factors analysisD.Vasile, O.Vasiliu, D.G.OjogRecent Advances in Risk Management, Assessment and Mitigation, 2010, 468-472

180. Cognitive risk factors for releapse in chronic schizophreniaD.Vasile, O.Vasiliu, A.G.Mangalagiu D.Vasile Recent Advances in Risk Management, Assessment and Mitigation, 2010, 473-475

181. Evaluation of the self-aggressive behavior risk factors in oncologic patientsD.Vasile, O.Vasiliu, G.GrigorescuRecent Advances in Risk Management, Assessment and Mitigation, 2010, 476-480

182. Suicide risk factors assessment in schizophreniaD.Vasile, O.Vasiliu, M.VasileRecent Advances in Risk Management, Assessment and Mitigation, 2010, 481-484

183. Management of affective symptoms and quality of life improvement after primary brain tumor surgeryD.Vasile, O.Vasiliu,

Proceedings of the World Medical Conference, september 2010, 276-278

31

184. Anticonvulsants for severe behavioral disturbances in Alzheimer dementiaD.Vasile, O.VasiliuProceedings of the World Medical Conference, september 2010,279-283

185. Management of Cognitive symptoms in dementia associated with Parkinson’s diseaseD.Vasile, O.Vasiliu,

Proceedings of the World Medical Conference, september 2010,284-286

186. Matching Psychotropics to Neurobiological Mechanisms in the Aftermath of a Traumatic Event: A Literature ReviewD.Vasile, O.Vasiliu, Proceedings of the World Medical Conference, september 2010,287-293.

187. Quality of life assessment in patients diagnosed with bipolar disorder and alcohol dependenceD.Vasile, O.Vasiliu, A.G.Mangalagiu, International Clinical Psychopharmacology 2011;26e (Suppl.A): 29

188. Quetiapine efficacy and tolerability in bipolar II disorder with comorbid cluster C personality disorderD.Vasile, O.Vasiliu, G.D.Ojog, International Clinical Psychopharmacology 2011;26e (Suppl.A): 29

189. Familial history of psychotic disorders in patients with bipolar I and II disorderD.Vasile, O.Vasiliu, A.G.Mangalagiu, International Clinical Psychopharmacology 2011;26e (Suppl.A): 29-30

190. Psychoactive substance induced manic episodes in a population ofyoung patients- a case seriesD.Vasile, O.Vasiliu, D.G.Ojog,

International Clinical Psychopharmacology 2011;26e (Suppl.A):30

191. An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine. Anand R, Geffen Y, Vasile D, Dan I.Clin Neuropharmacol 2010;3(6):297-302

192. The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: placebo-controlled study.

32

Heun R, Ahokas A, Boyer P, Gimenez-Montesinos N, Pontes-Soares F, Olivier V, Corral R, Berardo G, Lamaison H, Gargoloff P, Lupo C, Ahokas A, Jaaskelainen J, Jokinen R, Penttinen J, Pirila M, Riihikangas R, Timonen M, Nicolini H, Ontiveros J, Saucedo D, Saucedo E, Triay Peniche F, Marques Teixeira J, Lara E, Roldão Vieira C, Fernandes L, Fontes Ribeiro Aibili C, Dehelean P, Ienciu M, Prelipceanu D, Fodoreanu L, Oros G, Dan I, Vasile D, Ladea M.J Clin Psychiatry 2013;74(6):587-94.

Premii obţinute la congrese-conferinţe internaţionale

-ECNP Regional Poster Award: The effects of the adenosinic agonists and antagonists on behaviour and on EEG activityin rats. I.Cristescu, T.Raducanu, A.Zugravu, D.Vasile, S.Stoleru. 7th ECNP Regional Meeting 2002, Bucharest, Romania

-11th Congress of Balkan Military Medical Committee Best Poster Presentation Award: Augmenting Antidepressive Psychopharmacological Approach with Cognitive-Behavioral Therapy in Refractory Major Depressive Disorder. Vasiliu O, Vasile D, Sarmache M, Vasile M. 11th Congress of Balkan Military Medical Committee, 2006, Athens, Greece

-Balkan Military Medical Committee: First Prize from Romanian delegation for poster presentation during 12th Congress of BMMC. 2007, Poiana Brasov, Romania

-13th Congress of Balkan Military Medical Committee: First Prize Poster Award: Psychiatric Comorbidity in Somatoform Disorders. 2008, Kusadasi, Turkey